Publication details

 

Adipsin (Complement Factor D) As a New Biomarker of Body Fat Distribution in Extremely Obese Central-European Population

Basic information
Original title:Adipsin (Complement Factor D) As a New Biomarker of Body Fat Distribution in Extremely Obese Central-European Population
Authors:Julie Bienertová Vašků, Petr Bienert, Filip Zlámal, Josef Tomandl, Martin Forejt, Zlata Piskáčková, Martin Vavřina, Jana Kudělková, Anna Vašků
Further information
Citation:BIENERTOVÁ VAŠKŮ, Julie, Petr BIENERT, Filip ZLÁMAL, Josef TOMANDL, Martin FOREJT, Zlata PISKÁČKOVÁ, Martin VAVŘINA, Jana KUDĚLKOVÁ a Anna VAŠKŮ. Adipsin (Complement Factor D) As a New Biomarker of Body Fat Distribution in Extremely Obese Central-European Population. In Body Fat: Composition, Measurements and Reduction Procedures. 1. vyd. New York: Novapublishers, 2011. s. 14-27, 13 s. Body Fat: Composition, Measurements and Reduction. ISBN 978-1-61324-332-9.Export BibTeX
@inbook{938554,
author = {Bienertová Vašků, Julie and Bienert, Petr and Zlámal, Filip and Tomandl, Josef and Forejt, Martin and Piskáčková, Zlata and Vavřina, Martin and Kudělková, Jana and Vašků, Anna},
address = {New York},
booktitle = {Body Fat: Composition, Measurements and Reduction Procedures},
edition = {1.},
keywords = {adipsin; morbid obesity; body fat distribution},
language = {eng},
location = {New York},
isbn = {978-1-61324-332-9},
pages = {14-27},
publisher = {Novapublishers},
title = {Adipsin (Complement Factor D) As a New Biomarker of Body Fat Distribution in Extremely Obese Central-European Population},
year = {2011}
}
Original language:English
Field:Endocrinology, diabetology, metabolism, nutrition
Type:Chapter of a book
Keywords:adipsin; morbid obesity; body fat distribution

In this study, we identified strong positive correlations of adipsin plasma concentration with parameters of body fat distribution in extremely obese Central-European population, such as percentage of body fat and waist circumference, both considered important negative risk factors for obesity-associated comorbidities. More research is required to provide a better insight into the role of adipsin in obesity development to elucidate the underlying pathophysiological mechanisms of observed correlations.